CHRISTOPHER FRAGASSI: Open Payments
NPI 1164927935 · KINGSTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 17 payments from 8 companies in 2025. Trend: 2023 $335 · 2024 $760 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 2 | $232 |
| Teva Pharmaceuticals USA, Inc. | 6 | $209 |
| Janssen Pharmaceuticals, Inc | 1 | $100 |
| Otsuka America Pharmaceutical, Inc. | 1 | $68 |
| Indivior Inc. | 2 | $36 |
| Alkermes, Inc. | 2 | $35 |
| Neurocrine BioSciences, Inc. | 2 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
Products named: COBENFY, UZEDY, INVEGA SUSTENNA, ABILIFY MAINTENA, SUBLOCADE, ARISTADA, INGREZZA, CAPLYTA.
Industry payments across PA — which companies pay providers there.
